Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia

Affiliations

• ¹ Department of Paediatrics and Genetics, Ghent University, Ghent, Belgium.
• ² Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
• ³ Molecular and Cellular Oncology Laboratory, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
• ⁴ VIB Inflammation Research Centre, Ghent University, Ghent, Belgium.
• ⁵ Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
• ⁶ Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
• ⁷ Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
• ⁸ Department of Pathology and the Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
• ⁹ The Cancer Centre for Children, The Children's Hospital, Westmead, Australia.
• ¹⁰ University of Alabama at Birmingham, Birmingham, AL, USA.
• ¹¹ Women and Child Health Department, Haematology-Oncology Laboratory Istituto di Ricerca Pediatrica (IRP), University of Padova, Padova, Italy.
• ¹² Department of Genetics, University Hospital of Robert Debré and Paris-Diderot University, Paris, France.
• ¹³ Children's Cancer Institute, Lowy Cancer Research Centre UNSW, Sydney, New South Wales, Australia.
• ¹⁴ Laboratory of Onco-Haematology, Institut Necker Enfants-Malades, INSERM U1151, Paris, France.
• ¹⁵ The Máxima Centre for Paediatric Oncology/Haematology, Utrecht, the Netherlands.
• ¹⁶ Department of Pediatrics, UCSF Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.